| Transaction Date | Recipient | Shares | Type | Price | Value |
|---|---|---|---|---|---|
| 3rd July 2020 | Anthony C. J. Fernando | 17,949 | Exercise of derivative | $0.00 | |
| 30th June 2020 | Richard C Jr Pfenniger | 3,125 | Grant/award etc. | $0.00 | |
| 30th June 2020 | Brett Farabaugh | 30,000 | Exercise of derivative | $0.00 | |
| 30th June 2020 | Richard C Jr Pfenniger | 2,403 | Grant/award etc. | $0.00 | |
| 8th June 2020 | Richard C Jr Pfenniger | 6,213 | Grant/award etc. | $0.00 | |
| 8th June 2020 | Paul A Laviolette | 22,500 | Grant/award etc. | $0.00 | |
| 8th June 2020 | Paul A Laviolette | 8,901 | Grant/award etc. | $0.00 | |
| 8th June 2020 | Jane Ph D Hsiao | 22,500 | Grant/award etc. | $0.00 | |
| 8th June 2020 | Jane Ph D Hsiao | 7,988 | Grant/award etc. | $0.00 | |
| 8th June 2020 | Richard C Jr Pfenniger | 22,500 | Grant/award etc. | $0.00 |
Trans Enterix
Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 2/10.
TransEnterix, Inc. is a medical device company. It focuses on commercialization of Senhance System, that digitizes laparoscopic minimally invasive surgery. The company was founded by William N. Starling in 2006.
Ticker: TRXC
Sector: Commercial Services
Industry: Miscellaneous Commercial Services
SEC Central Index Key (CIK): 876378
Employees: 163
Exchange: NYSE American
Auditor Opinion:
You must Login to see Language Changes
Disclosure Language changes
You must Login to see analysis
Red Flags
Restructuring Charges of $900 Th for the period Jan 2020 to Jun 2020 in the context of Employee severance
Restructuring Charges of $858 Th for the period Jan 2020 to Jun 2020 in the context of all up
Restructuring Charges of $9 M for the period Oct 2019 to Dec 2019 in the context of all up
Restructuring Charges of $7 M for the period Oct 2019 to Dec 2019 in the context of Cost of sales
Restructuring Charges of $1 M for the period Oct 2019 to Dec 2019 in the context of Restructuring and other charges
Goodwill Impairment Loss of $79 M for the period Oct 2019 to Dec 2019 in the context of all up
Fundamentals
Cash at Carrying Value: $16 M (0%)
Inventory, Net: $11 M (0%)
Other Assets, Current: $7 M (-2%)
Assets, Current: $34 M (22%)
Property, Plant and Equipment, Net: $7 M (47%)
Other Assets, Noncurrent: $2 M (-23%)
Assets: $76 M (1%)
Accounts Payable, Current: $2 M (-34%)
Accrued Liabilities, Current: $7 M (-20%)
Liabilities, Current: $10 M (-22%)
Other Liabilities, Noncurrent: $1 M (-22%)
Liabilities: $16 M (-14%)
Common Stock, Value, Issued: $57 Th (171%)
Common Stock, Shares, Issued: $57 M (175%)
Additional Paid in Capital, Common Stock: $755 M (4%)
Retained Earnings (Accumulated Deficit): $694 M (0%)
Accumulated Other Comprehensive Income (Loss), Net of Tax: $1 M (-6%)
Stockholders' Equity (Parent): $60 M (0%)
Liabilities and Equity: $76 M (1%)
Revenue: $655 Th (0%)
Cost of Revenue: $1 M (-55%)
Gross Margin: $758 Th (-60%)
Research and Development: $4 M (-48%)
Sales and Marketing: $3 M (-59%)
General and Administrative Expenses: $4 M (-48%)
Restructuring Charges: $858 Th (-90%)
Operating Income/Loss: $14 M (-54%)
Other Income, net: $165 Th (-46%)
Provision for income taxes: $691 Th (-50%)
EPS (basic): $0.27 (-64%)
EPS (diluted): $0.27 (-64%)
News
What we know about Amy Coney Barrett's judicial abortion record
27th September 2020
US shale producers Devon, WPX Energy in merger talks
26th September 2020
What we know about Amy Coney Barrett's judicial abortion record
26th September 2020
What we know about Amy Coney Barrett's judicial abortion record
26th September 2020
What Amy Coney Barrett on the Supreme Court would mean for abortion rights
25th September 2020